{"transactions":[{"id":696941,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-04T19:15:32.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":24.92,"value":47348.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":92562,"source":{"system":"sec-edgar","filing":"0001193125-26-332547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526332547/ownership.xml","form_type":"4"}},{"id":737489,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:46:33.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1899,"price":24.62,"value":46753.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":94462,"source":{"system":"sec-edgar","filing":"0001677455-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000167745526000002/ownership.xml","form_type":"4"}},{"id":758383,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:09:48.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000119312526249114/ownership.xml","form_type":"4"}},{"id":804337,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-20T21:15:00.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":49960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":49960,"derivative":{"exercise_price":24.52,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":49960},"source":{"system":"sec-edgar","filing":"0001193125-26-164281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526164281/ownership.xml","form_type":"4"}},{"id":804336,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-20T21:15:00.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":28895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":95715,"source":{"system":"sec-edgar","filing":"0001193125-26-164281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526164281/ownership.xml","form_type":"4"}},{"id":850442,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:51:40.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":3508,"price":22.67,"value":79526.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":66820,"source":{"system":"sec-edgar","filing":"0001193125-26-100309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526100309/ownership.xml","form_type":"4"}},{"id":850441,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:51:40.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":6018,"price":21.4,"value":128785.2,"ownership":{"direct":true},"balance_after":70328,"source":{"system":"sec-edgar","filing":"0001193125-26-100309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526100309/ownership.xml","form_type":"4"}},{"id":865576,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:51:48.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":8135,"price":22.8,"value":185478.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 73 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on October 31, 2025"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":76346,"source":{"system":"sec-edgar","filing":"0001193125-26-089111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089111/ownership.xml","form_type":"4"}},{"id":865575,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:51:48.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":11137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics."}],"balance_after":84408,"source":{"system":"sec-edgar","filing":"0001193125-26-089111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089111/ownership.xml","form_type":"4"}},{"id":892720,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T01:57:48.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":45559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":77742,"source":{"system":"sec-edgar","filing":"0001570562-26-000027","document":"wk-form4_1771552664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056226000027/wk-form4_1771552664.xml","form_type":"4"}},{"id":1041291,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:11:58.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":2450,"price":31.17,"value":76366.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":73271,"source":{"system":"sec-edgar","filing":"0001677455-25-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000167745525000005/ownership.xml","form_type":"4"}},{"id":1128874,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:48:35.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000095017025079941/ownership.xml","form_type":"4"}},{"id":1205425,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T21:59:45.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":12888,"price":12.9939,"value":167465.3832,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $12.98 to $13.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32183,"source":{"system":"sec-edgar","filing":"0001570562-25-000046","document":"wk-form4_1741989579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000046/wk-form4_1741989579.xml","form_type":"4"}},{"id":1211607,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T22:53:15.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":11146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":11146,"derivative":{"exercise_price":13.58,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":11146},"source":{"system":"sec-edgar","filing":"0001570562-25-000035","document":"wk-form4_1741733588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000035/wk-form4_1741733588.xml","form_type":"4"}},{"id":1211606,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T22:53:15.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":7364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":45071,"source":{"system":"sec-edgar","filing":"0001570562-25-000035","document":"wk-form4_1741733588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000035/wk-form4_1741733588.xml","form_type":"4"}},{"id":1226918,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:18:24.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":12846,"price":42.1,"value":540816.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.77 to $42.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":75287,"source":{"system":"sec-edgar","filing":"0000950170-25-032798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032798/ownership.xml","form_type":"4"}},{"id":1226917,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:18:24.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":18443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric."}],"balance_after":88133,"source":{"system":"sec-edgar","filing":"0000950170-25-032798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032798/ownership.xml","form_type":"4"}},{"id":1235313,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T18:58:32.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":26074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":26074,"derivative":{"exercise_price":42.92,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":26074},"source":{"system":"sec-edgar","filing":"0000950170-25-030639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025030639/ownership.xml","form_type":"4"}},{"id":1235312,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T18:58:32.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":14494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 205 shares acquired on October 31, 2024 under the Company's Amended and Restated Employee Stock Purchase Plan"}],"balance_after":69690,"source":{"system":"sec-edgar","filing":"0000950170-25-030639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025030639/ownership.xml","form_type":"4"}},{"id":1235311,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T18:58:32.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":760,"price":42.75,"value":32490.0,"ownership":{"direct":true},"balance_after":54991,"source":{"system":"sec-edgar","filing":"0000950170-25-030639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025030639/ownership.xml","form_type":"4"}},{"id":1235310,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-03T18:58:32.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":2230,"price":42.93,"value":95733.9,"ownership":{"direct":true},"balance_after":55751,"source":{"system":"sec-edgar","filing":"0000950170-25-030639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025030639/ownership.xml","form_type":"4"}},{"id":1383387,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-10-22T00:39:34.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 31, 2025, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":34000,"derivative":{"exercise_price":2.04,"exercise_date":"2025-05-31","expiration_date":"2034-10-17","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000950170-24-116061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000095017024116061/ownership.xml","form_type":"4"}},{"id":1481772,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-06-12T23:47:14.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":9806,"price":45,"value":441270.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 447 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":57981,"source":{"system":"sec-edgar","filing":"0000950170-24-072621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024072621/ownership.xml","form_type":"4"}},{"id":1594537,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T01:22:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":31400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":31400,"derivative":{"exercise_price":53.69,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":31400},"source":{"system":"sec-edgar","filing":"0000950170-24-026666","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026666/ownership.xml","form_type":"4"}},{"id":1594536,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:22:18.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":3756,"price":53.76,"value":201922.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 357 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on October 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":67340,"source":{"system":"sec-edgar","filing":"0000950170-24-026666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026666/ownership.xml","form_type":"4"}},{"id":1594535,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:22:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric."}],"balance_after":70739,"source":{"system":"sec-edgar","filing":"0000950170-24-026666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026666/ownership.xml","form_type":"4"}},{"id":1594534,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:22:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":17800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"}],"balance_after":69782,"source":{"system":"sec-edgar","filing":"0000950170-24-026666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026666/ownership.xml","form_type":"4"}},{"id":1651243,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T23:37:12.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":9377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":9377,"derivative":{"exercise_price":13.15,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":9377},"source":{"system":"sec-edgar","filing":"0001570562-24-000021","document":"wk-form4_1707521822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000021/wk-form4_1707521822.xml","form_type":"4"}},{"id":1651242,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T23:37:12.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":6464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 7, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":37707,"source":{"system":"sec-edgar","filing":"0001570562-24-000021","document":"wk-form4_1707521822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000021/wk-form4_1707521822.xml","form_type":"4"}},{"id":1660848,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:57:32.000Z","date":"2024-01-30","kind":"sale","planned":true,"acquired":false,"shares":11931,"price":13.1366,"value":156732.7746,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $13.025 to $13.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31243,"source":{"system":"sec-edgar","filing":"0001570562-24-000005","document":"wk-form4_1706911039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000005/wk-form4_1706911039.xml","form_type":"4"}},{"id":1858234,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-13T00:24:56.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":29532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":29532,"derivative":{"exercise_price":7.12,"exercise_date":"2024-06-09","expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":29532},"source":{"system":"sec-edgar","filing":"0001209191-23-036512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000120919123036512/doc4.xml","form_type":"4"}},{"id":1902257,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-05-05T18:16:23.000Z","date":"2023-05-04","kind":"sale","planned":false,"acquired":false,"shares":4378,"price":45,"value":197010.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 221 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":51982,"source":{"system":"sec-edgar","filing":"0001209191-23-027601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123027601/doc4.xml","form_type":"4"}},{"id":1972006,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T00:59:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":39400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":39400,"derivative":{"exercise_price":45.65,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":39400},"source":{"system":"sec-edgar","filing":"0001209191-23-016047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016047/doc4.xml","form_type":"4"}},{"id":1972005,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:59:40.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":3161,"price":45.25,"value":143035.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 199 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":56139,"source":{"system":"sec-edgar","filing":"0001209191-23-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016047/doc4.xml","form_type":"4"}},{"id":1972004,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:59:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":59101,"source":{"system":"sec-edgar","filing":"0001209191-23-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016047/doc4.xml","form_type":"4"}},{"id":1972003,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:59:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":2663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric."}],"balance_after":37101,"source":{"system":"sec-edgar","filing":"0001209191-23-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016047/doc4.xml","form_type":"4"}},{"id":2039980,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T01:41:46.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":11789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":11789,"derivative":{"exercise_price":10.25,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":11789},"source":{"system":"sec-edgar","filing":"0001570562-23-000023","document":"wf-form4_167521568896760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000023/wf-form4_167521568896760.xml","form_type":"4"}},{"id":2039979,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T01:41:46.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":8293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":43174,"source":{"system":"sec-edgar","filing":"0001570562-23-000023","document":"wf-form4_167521568896760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000023/wf-form4_167521568896760.xml","form_type":"4"}},{"id":2147556,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T23:56:01.000Z","date":"2022-04-21","kind":"grant","acquired":true,"shares":30425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vests on March 1, 2023. Thereafter,  1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested."}],"balance_after":30425,"derivative":{"exercise_price":6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":30425},"source":{"system":"sec-edgar","filing":"0001209191-22-051983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000120919122051983/doc4.xml","form_type":"4"}},{"id":2161980,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-09-09T23:25:05.000Z","date":"2022-09-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant  or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.82,"exercise_date":"2023-09-08","expiration_date":"2032-09-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-049362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000120919122049362/doc4.xml","form_type":"4"}},{"id":2343818,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-08T17:25:43.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":5140,"price":62.95,"value":323563.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.89 to $63.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":34438,"source":{"system":"sec-edgar","filing":"0001209191-22-016931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122016931/doc4.xml","form_type":"4"}},{"id":2353053,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T23:08:23.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":24900,"derivative":{"exercise_price":67.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0001209191-22-015811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015811/doc4.xml","form_type":"4"}},{"id":2353052,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-03T23:08:23.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 106 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":39578,"source":{"system":"sec-edgar","filing":"0001209191-22-015811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015811/doc4.xml","form_type":"4"}},{"id":2353051,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-03T23:08:23.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":2886,"price":66.62,"value":192265.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.62 to $66.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":25472,"source":{"system":"sec-edgar","filing":"0001209191-22-015811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015811/doc4.xml","form_type":"4"}},{"id":2424951,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T02:01:53.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":22727,"derivative":{"exercise_price":5.46,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001570562-22-000050","document":"wf-form4_164324889718833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056222000050/wf-form4_164324889718833.xml","form_type":"4"}},{"id":2424950,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T02:01:53.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":15568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer"}],"balance_after":34881,"source":{"system":"sec-edgar","filing":"0001570562-22-000050","document":"wf-form4_164324889718833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056222000050/wf-form4_164324889718833.xml","form_type":"4"}},{"id":2459264,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T22:58:40.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":19495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option shall vest and become exercisable on January 22, 2022 and 1/36th of the shares subject to the option shall vest monthly thereafter provided that the Reporting Person remains a service provider to the Issuer on each vest date."}],"balance_after":19495,"derivative":{"exercise_price":20.99,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":19495},"source":{"system":"sec-edgar","filing":"0001209191-21-071136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000120919121071136/doc4.xml","form_type":"4"}},{"id":2540333,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-10-18T22:46:46.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":310,"price":81.14,"value":25153.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":28358,"source":{"system":"sec-edgar","filing":"0001209191-21-060752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121060752/doc4.xml","form_type":"4"}},{"id":2574460,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T22:22:25.000Z","date":"2021-09-08","kind":"exercise","acquired":false,"shares":7336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":17664,"derivative":{"exercise_price":54.5,"expiration_date":"2026-06-20","underlying":"Common Stock","underlying_shares":7336},"source":{"system":"sec-edgar","filing":"0001209191-21-055362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121055362/doc4.xml","form_type":"4"}},{"id":2574459,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-09-09T22:22:25.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":7336,"price":100.65,"value":738368.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":28668,"source":{"system":"sec-edgar","filing":"0001209191-21-055362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121055362/doc4.xml","form_type":"4"}},{"id":2574458,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-09-09T22:22:25.000Z","date":"2021-09-08","kind":"exercise","acquired":true,"shares":7336,"price":54.5,"value":399812.0,"ownership":{"direct":true},"balance_after":36004,"source":{"system":"sec-edgar","filing":"0001209191-21-055362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121055362/doc4.xml","form_type":"4"}},{"id":2658216,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:33:09.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This grant represents the annual grant to members of the Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":35.09,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-21-000929","document":"e620749_4-parschauer.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000119380521000929/e620749_4-parschauer.xml","form_type":"4"}},{"id":2671388,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-12T01:08:31.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":1329,"price":100,"value":132900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":28668,"source":{"system":"sec-edgar","filing":"0001209191-21-040108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121040108/doc4.xml","form_type":"4"}},{"id":2720558,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-10T22:13:56.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":313,"price":113.67,"value":35578.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 83 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":29997,"source":{"system":"sec-edgar","filing":"0001209191-21-031388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121031388/doc4.xml","form_type":"4"}},{"id":2811749,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T01:47:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":11000,"derivative":{"exercise_price":142.47,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-21-017559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017559/doc4.xml","form_type":"4"}},{"id":2811748,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-04T01:47:24.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3970,"price":138.17,"value":548534.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.16 to $138.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":30227,"source":{"system":"sec-edgar","filing":"0001209191-21-017559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017559/doc4.xml","form_type":"4"}},{"id":2811747,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-04T01:47:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":4636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 1,530 shares of common stock and 3,106 RSUs into which previously granted performance stock units were converted on March 1, 2021 upon certification of the performance metric. The RSUs will fully vest on March 1, 2022."}],"balance_after":34197,"source":{"system":"sec-edgar","filing":"0001209191-21-017559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017559/doc4.xml","form_type":"4"}},{"id":2811746,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-04T01:47:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":29561,"source":{"system":"sec-edgar","filing":"0001209191-21-017559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017559/doc4.xml","form_type":"4"}},{"id":2871243,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T22:12:12.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":19313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 5, 2021, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":19313,"source":{"system":"sec-edgar","filing":"0001570562-21-000035","document":"wf-form4_161290871645474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000035/wf-form4_161290871645474.xml","form_type":"4"}},{"id":2996276,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-02T22:05:57.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":9903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":54.5,"expiration_date":"2026-06-20","underlying":"Common Stock","underlying_shares":9903},"source":{"system":"sec-edgar","filing":"0001209191-20-056428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056428/doc4.xml","form_type":"4"}},{"id":2996275,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-02T22:05:57.000Z","date":"2020-10-30","kind":"sale","acquired":false,"shares":9903,"price":100.12,"value":991488.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 93 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":24061,"source":{"system":"sec-edgar","filing":"0001209191-20-056428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056428/doc4.xml","form_type":"4"}},{"id":2996274,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-02T22:05:57.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":9903,"price":54.5,"value":539713.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":33871,"source":{"system":"sec-edgar","filing":"0001209191-20-056428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056428/doc4.xml","form_type":"4"}},{"id":2997311,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-30T21:28:14.000Z","date":"2020-10-28","kind":"exercise","acquired":false,"shares":97,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":34903,"derivative":{"exercise_price":54.5,"expiration_date":"2026-06-20","underlying":"Common Stock","underlying_shares":97},"source":{"system":"sec-edgar","filing":"0001209191-20-056344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056344/doc4.xml","form_type":"4"}},{"id":2997310,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-30T21:28:14.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":97,"price":100,"value":9700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":23968,"source":{"system":"sec-edgar","filing":"0001209191-20-056344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056344/doc4.xml","form_type":"4"}},{"id":2997309,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-30T21:28:14.000Z","date":"2020-10-28","kind":"exercise","acquired":true,"shares":97,"price":54.5,"value":5286.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":24065,"source":{"system":"sec-edgar","filing":"0001209191-20-056344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120056344/doc4.xml","form_type":"4"}},{"id":3004886,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-16T23:21:29.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":325,"price":88,"value":28600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":23968,"source":{"system":"sec-edgar","filing":"0001209191-20-055179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120055179/doc4.xml","form_type":"4"}},{"id":3007965,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T21:53:36.000Z","date":"2020-10-08","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date."}],"balance_after":35000,"derivative":{"exercise_price":54.5,"expiration_date":"2026-06-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-054710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054710/doc4.xml","form_type":"4"}},{"id":3007964,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-13T21:53:36.000Z","date":"2020-10-08","kind":"sale","acquired":false,"shares":10000,"price":95,"value":950000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":24293,"source":{"system":"sec-edgar","filing":"0001209191-20-054710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054710/doc4.xml","form_type":"4"}},{"id":3007963,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-13T21:53:36.000Z","date":"2020-10-08","kind":"exercise","acquired":true,"shares":10000,"price":54.5,"value":545000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":34293,"source":{"system":"sec-edgar","filing":"0001209191-20-054710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054710/doc4.xml","form_type":"4"}},{"id":3010640,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-07T18:57:57.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested with respect to 1/4th of the shares on March 1, 2019 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option will fully vest on the fourth anniversary of the grant date."}],"balance_after":17000,"derivative":{"exercise_price":48.43,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-054110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054110/doc4.xml","form_type":"4"}},{"id":3010639,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-07T18:57:57.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":10000,"price":90,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":24293,"source":{"system":"sec-edgar","filing":"0001209191-20-054110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054110/doc4.xml","form_type":"4"}},{"id":3010638,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-07T18:57:57.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":10000,"price":48.43,"value":484300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":34293,"source":{"system":"sec-edgar","filing":"0001209191-20-054110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120054110/doc4.xml","form_type":"4"}},{"id":3022795,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-24T20:47:18.000Z","date":"2020-09-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested with respect to 1/4th of the shares on March 1, 2019 (the first anniversary of the grant date of the option or the \"Option Anniversary Date\") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option will fully vest on the fourth anniversary of the grant date."}],"balance_after":27000,"derivative":{"exercise_price":48.43,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-051900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120051900/doc4.xml","form_type":"4"}},{"id":3022794,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-24T20:47:18.000Z","date":"2020-09-23","kind":"sale","acquired":false,"shares":10000,"price":85,"value":850000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":24293,"source":{"system":"sec-edgar","filing":"0001209191-20-051900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120051900/doc4.xml","form_type":"4"}},{"id":3022793,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-24T20:47:18.000Z","date":"2020-09-23","kind":"exercise","acquired":true,"shares":10000,"price":48.43,"value":484300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":34293,"source":{"system":"sec-edgar","filing":"0001209191-20-051900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120051900/doc4.xml","form_type":"4"}},{"id":3051949,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-19T18:12:21.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares vested one year from June 20, 2016 and then 1/48th of the option vested monthly thereafter."}],"balance_after":45000,"derivative":{"exercise_price":54.5,"expiration_date":"2026-06-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-047456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120047456/doc4.xml","form_type":"4"}},{"id":3051948,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-08-19T18:12:21.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":2370,"price":88.39,"value":209484.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":24293,"source":{"system":"sec-edgar","filing":"0001209191-20-047456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120047456/doc4.xml","form_type":"4"}},{"id":3051947,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-08-19T18:12:21.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":10000,"price":88.44,"value":884400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.29 to $88.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":26663,"source":{"system":"sec-edgar","filing":"0001209191-20-047456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120047456/doc4.xml","form_type":"4"}},{"id":3051946,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-08-19T18:12:21.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":10000,"price":54.5,"value":545000.0,"ownership":{"direct":true},"balance_after":36663,"source":{"system":"sec-edgar","filing":"0001209191-20-047456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120047456/doc4.xml","form_type":"4"}},{"id":3100482,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-25T00:02:29.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the options vest monthly over a one year period from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":40.7,"expiration_date":"2030-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000746","document":"e619725_4-parschauer.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000119380520000746/e619725_4-parschauer.xml","form_type":"4"}},{"id":3102836,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-06-22T17:46:19.000Z","date":"2020-06-20","kind":"tax_withholding","acquired":false,"shares":649,"price":78.22,"value":50764.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":26663,"source":{"system":"sec-edgar","filing":"0001209191-20-038110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120038110/doc4.xml","form_type":"4"}},{"id":3142170,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-05-19T23:12:25.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":2722,"price":74.715,"value":203374.23,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 130 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":27312,"source":{"system":"sec-edgar","filing":"0001209191-20-030707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120030707/doc4.xml","form_type":"4"}},{"id":3156027,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-05-09T00:02:48.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":248,"price":66.26,"value":16432.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":29904,"source":{"system":"sec-edgar","filing":"0001209191-20-028111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120028111/doc4.xml","form_type":"4"}},{"id":3172205,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-04-21T19:36:37.000Z","date":"2020-04-19","kind":"tax_withholding","acquired":false,"shares":248,"price":58.57,"value":14525.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":30152,"source":{"system":"sec-edgar","filing":"0001209191-20-025191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120025191/doc4.xml","form_type":"4"}},{"id":3230975,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T01:00:06.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":22000,"derivative":{"exercise_price":56.08,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-20-015763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015763/doc4.xml","form_type":"4"}},{"id":3230974,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:06.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":2118,"price":56.08,"value":118777.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":30400,"source":{"system":"sec-edgar","filing":"0001209191-20-015763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015763/doc4.xml","form_type":"4"}},{"id":3230973,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:06.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":5634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":32518,"source":{"system":"sec-edgar","filing":"0001209191-20-015763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015763/doc4.xml","form_type":"4"}},{"id":3230972,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T01:00:06.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":26884,"source":{"system":"sec-edgar","filing":"0001209191-20-015763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015763/doc4.xml","form_type":"4"}},{"id":3302452,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-25T02:06:22.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":23458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":23458,"derivative":{"exercise_price":10.19,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":23458},"source":{"system":"sec-edgar","filing":"0001570562-20-000034","document":"wf-form4_157991796400306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056220000034/wf-form4_157991796400306.xml","form_type":"4"}},{"id":3386080,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-30T00:40:35.000Z","date":"2019-10-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the options vest monthly over a two year period from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":10.23,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-026159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000089924319026159/doc4.xml","form_type":"4"}},{"id":3386079,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-30T00:40:35.000Z","date":"2019-10-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the options vest monthly over a one year period from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":10.23,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-026159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000089924319026159/doc4.xml","form_type":"4"}},{"id":3392721,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-10-16T23:28:21.000Z","date":"2019-10-14","kind":"grant","acquired":true,"shares":1434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19084,"source":{"system":"sec-edgar","filing":"0001209191-19-053324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119053324/doc4.xml","form_type":"4"}},{"id":3459626,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T20:31:14.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":26163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of July 15, 2019."}],"balance_after":26163,"derivative":{"exercise_price":15.99,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":26163},"source":{"system":"sec-edgar","filing":"0001570562-19-000114","document":"wf-form4_156339545939626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056219000114/wf-form4_156339545939626.xml","form_type":"4"}},{"id":3479807,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-25T01:16:15.000Z","date":"2019-06-24","kind":"sale","acquired":false,"shares":1226,"price":61.5,"value":75399.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.78 to $62.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":17650,"source":{"system":"sec-edgar","filing":"0001209191-19-038876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119038876/doc4.xml","form_type":"4"}},{"id":3479806,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-25T01:16:15.000Z","date":"2019-06-21","kind":"sale","acquired":false,"shares":1489,"price":63.01,"value":93821.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001209191-19-038876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119038876/doc4.xml","form_type":"4"}},{"id":3479805,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-06-25T01:16:15.000Z","date":"2019-06-20","kind":"tax_withholding","acquired":false,"shares":649,"price":63.48,"value":41198.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":20365,"source":{"system":"sec-edgar","filing":"0001209191-19-038876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119038876/doc4.xml","form_type":"4"}},{"id":3536255,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-05-07T23:01:47.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":1434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on May 6, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":21014,"source":{"system":"sec-edgar","filing":"0001209191-19-028097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119028097/doc4.xml","form_type":"4"}},{"id":3545299,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-04-30T22:32:59.000Z","date":"2019-04-29","kind":"sale","acquired":false,"shares":468,"price":68.3,"value":31964.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19580,"source":{"system":"sec-edgar","filing":"0001209191-19-026669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119026669/doc4.xml","form_type":"4"}},{"id":3550973,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-04-23T22:26:32.000Z","date":"2019-04-19","kind":"tax_withholding","acquired":false,"shares":248,"price":64.43,"value":15978.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":20048,"source":{"system":"sec-edgar","filing":"0001209191-19-025614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025614/doc4.xml","form_type":"4"}},{"id":3553334,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T21:52:59.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":21500,"derivative":{"exercise_price":67.55,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-19-025104","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025104/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}}],"next_cursor":"2019-04-17T21:52:59.000000Z,3553334"}